Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Cash Interest Paid Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Cash Interest Paid
$2.8m
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
ProQR Therapeutics NV
NASDAQ:PRQR
Cash Interest Paid
€1.2m
CAGR 3-Years
-19%
CAGR 5-Years
88%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Cash Interest Paid
$20.8m
CAGR 3-Years
58%
CAGR 5-Years
48%
CAGR 10-Years
25%
argenx SE
XBRU:ARGX
Cash Interest Paid
$290k
CAGR 3-Years
-24%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Cash Interest Paid?
Cash Interest Paid
2.8m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Cash Interest Paid amounts to 2.8m USD.

What is Pharming Group NV's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-16%

Over the last year, the Cash Interest Paid growth was -30%. The average annual Cash Interest Paid growth rates for Pharming Group NV have been -10% over the past three years , -16% over the past five years .

Back to Top